InvestorsHub Logo
Followers 21
Posts 1025
Boards Moderated 0
Alias Born 04/07/2008

Re: midastouch017 post# 2890

Friday, 11/27/2020 1:12:18 AM

Friday, November 27, 2020 1:12:18 AM

Post# of 3353
Same for me, I have held onto my shares. At a minimum I hope the upcoming MS data might give it a nudge up back to break even, and there is still apparent potential for ALS. If we can go with management's words, maybe even without another ALS trial.

The data will need to be viewed in its entirety. There really is not good out there for ALS, and NurOWN did work as intended. As long as there are no safety issues, there may be a path forward for approval. It cannot be denied what was seen in some patients, including Matt Bellina which is the only person we know did get the treatment. It clearly works in a group of patients, question is how will the FDA seek to proceed on this.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCLI News